FDA Commissioner Scott Gottlieb discussed briefly the agency's draft guidance regarding communication of health care economic information at a Nov. 30 congressional hearing, and said the objective at the agency is to "go beyond the draft guidance to provide a framework" for sponsors' communication of such data to formularies and others.